Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: J Clin Pharmacol. 2020 Sep 22;61(3):378–387. doi: 10.1002/jcph.1743

Table 3.

Attainment of goal concentrations from simulations

Dose Target attainment (%) Concentrations1 (mg/L)
Goal: Peak concentration between 20–40 mg/L 2 hours post-dose
30 mg/kg 74.8% 26.7 ± 7.9
40 mg/kg 68.9% 35.7 ± 10.0
Goal: Trough concentration between 20–40 mg/L at 7 days
5 mg/kg/day 61.0% 23.6 ± 7.6
6 mg/kg/day 72.6% 26.4 ± 8.3
7 mg/kg/day 72.7% 29.9 ± 9.1
Goal: Trough concentration between 20–40 mg/L at 20 days
5 mg/kg/day 49.6 % 22.7 ± 9.4
6 mg/kg/day 59.0 % 26.4 ± 10.7
7 mg/kg/day 59.5 % 31.2 ± 12.8
On renal replacement therapy
Goal: Peak concentration between 20–40 mg/L 2 hours post-dose
30 mg/kg 72.0% 24.6 ± 6.5
40 mg/kg 76.1% 32.7 ± 9.0
Goal: Trough concentration between 20–40 mg/L at 7 days
45 mg/kg/day given as divided doses q12h 50.4% 27.6 ± 14.4
45 mg/kg/day given as divided doses q8h 52.3% 31.1 ± 15.4
40 mg/kg/day given as divided doses q6h 57.1% 28.2 ± 12.7
1

Mean value ± SD